# Portico Next Generation Approval Study

> **NCT04011722** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Abbott Medical Devices** · enrollment: 333 (actual)

## Conditions studied

- Symptomatic Severe Aortic Stenosis

## Interventions

- **DEVICE:** Portico™ NG (Navitor) Valve and FlexNav™ Delivery System
- **DEVICE:** Navitor Titan Valve (35mm) Valve and Large FlexNav™ Delivery System

## Key facts

- **NCT ID:** NCT04011722
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-09-17
- **Primary completion:** 2023-01-12
- **Final completion:** 2027-12
- **Target enrollment:** 333 (ACTUAL)
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04011722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04011722, "Portico Next Generation Approval Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04011722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*